Plasma and leukocytic bactericidal activity in the course of chemotherapy of Hodgkin's disease.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001770:Blood Bactericidal Activity / Q000187:drug effects*; D005260:Female; D006098:Granulocytes / Q000276:immunology*; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D008297:Male; D008466:Mechlorethamine / Q000008:administration & dosage; D008875:Middle Aged; D009000:Monocytes / Q000276:immunology*; D010587:Phagocytosis / Q000187:drug effects; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone